CXCR4 and Miyoshi myopathy: Previously, we and others have already demonstrated the feasibility of CXCR4-directed PET imaging as a suitable tool for both non-invasive detection of MM lesions as well as patient identification for CXCR4-directed therapy with pilot studies suggesting the feasibility of CXCR4-directed radioligand therapy as a novel treatment approach for MM 29.